Chronic Kidney Disease: Diagnosis and Treatment, Volume II

Dear Colleagues,

Chronic kidney disease (CKD) is defined as decreased kidney function shown by glomerular filtration rate (GFR) of less than 60 mL/min per 1.73 m², or presence of one or more markers of kidney damage (including albuminuria, proteinuria, hematuria, urine sediment abnormalities, electrolyte abnormalities due to tubular disorders, abnormalities on histology, structural abnormalities detected by imaging, or history of kidney transplantation), and at least 3 months of duration. CKD could arise from many different disease pathways that deteriorate renal function irreversibly over months or years, while diabetes mellitus and hypertension are the main causes of CKD worldwide.

Treatment strategies of CKD patients usually contain managements of diabetes mellitus and hypertension, avoiding nephrotoxins, adjustment in drug dosing, reducing risk of cardiovascular disease, diet adjustment, and treating complications. When GFR is less than 15 mL/min per 1.73m², the patient has reached end stage renal disease (ESRD). The kidneys are no longer able to cope with waste and fluid clearance on their own. Options for patients with ESRD are kidney replacement therapy (dialysis or kidney transplantation), or conservative care, as known as palliation or non-dialytic care.

The second edition of this Special Issue, "Chronic Kidney Disease: Diagnosis and Treatment", is dedicated to original papers, brief reports, or reviews that provide further understanding or novel opinions on diagnosis and treatment for CKD. For scholars, traditional cell culture models may be not adequate for studying the functional intricacies of the kidney. Recent experiments have offered improvements for understanding these systems, including organoid modeling, 3D bioprinting, decellularization, microfluidics, and other potential applications of kidney bioengineering. We look forward to your valued research to make this Special Issue a reference resource.

Dr. Po-Jen Hsiao
Prof. Dr. Chi-Ming Chu
Prof. Dr. Chi-Wen Chang
Prof. Dr. Hao-Yun Kao
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Bioengineering is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

• kidney bioengineering
• chronic kidney disease (CKD)
• glomerular filtration rate (GFR)
• end-stage renal disease (ESRD)
• kidney injury
• nephrotoxins
• kidney replacement therapy
• kidney transplantation